Table 1.
Gonorrhoea patient characteristics in 2016 and 2019
| 2016 | 2019 | |
|---|---|---|
| N (%) | N (%) | |
| Total number of isolatesa | 2559 | 3239 |
| Sex | ||
| Male | 2158 (84.7) | 2676 (84.2) |
| Female | 391 (15.3) | 502 (15.8) |
| Not reported | 10 | 61 |
| Age (years) | ||
| < 25 | 668 (26.5) | 883 (28.4) |
| ≥ 25 | 1854 (73.5) | 2223 (71.6) |
| Not reported | 37 | 133 |
| Sexual orientation and sex | ||
| Females | 391 (24.4) | 501 (25.6) |
| Heterosexual males | 539 (33.6) | 545 (27.9)* |
| Men who have sex with men | 672 (41.9) | 908 (46.5)* |
| Not reported | 957 | 1285 |
| Site of infection | ||
| Urogenital | 1745 (75.1) | 2076 (71.5)* |
| Pharyngeal | 153 (6.6) | 262 (9.0)* |
| Anorectal | 329 (14.2) | 475 (16.4)* |
| Other | 97 (4.2) | 91 (3.1)* |
| Not reported | 235 | 335 |
| Previous gonorrhoea | ||
| Yes | 163 (16.7) | 228 (23.2)* |
| No | 814 (83.3) | 753 (76.8)* |
| Not reported | 1582 | 2258 |
| Concurrent sexually transmitted infection (STI) | ||
| Concurrent chlamydia infection | 181 (23.5) | 228 (21.2) |
| Concurrent other STI (not HIV) | 51 (6.6) | 83 (7.7) |
| No concurrent STI | 539 (69.9) | 764 (71.1) |
| Not reported | 1788 | 2164 |
| HIV status | ||
| Positive | 143 (15.8) | 139 (13.1) |
| Negative | 760 (84.2) | 926 (86.9) |
| Not reported | 1656 | 2174 |
aTotal number of isolates includes a maximum of 200 isolates per country. Three countries exceeded the 200 isolate limit in 2016; The Netherlands, Spain and the UK. In 2019 seven countries exceeded 200 isolates; Austria, Finland, France, The Netherlands, Norway, Spain and the UK
*Bold letters indicate significant difference between 2016 and 2019 by Z-test (p < 0.05)